Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
12.47
+0.10 (0.81%)
At close: Jun 27, 2025, 4:00 PM
13.10
+0.63 (5.05%)
After-hours: Jun 27, 2025, 7:04 PM EDT
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $868.95 million as of June 27, 2025. Its market cap has increased by 27.88% in one year.
Market Cap
868.95M
Enterprise Value
565.81M
1-Year Change
27.88%
Ranking
Category
Stock Price
$12.47
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $868.95M, an increase of 163.80%. That is a compound annual growth rate of 12.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 869.00M | -13.82% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.92B |
| Johnson & Johnson | 366.76B |
| AbbVie | 329.73B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 275.13B |
| Abbott Laboratories | 232.63B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |